Cargando…

Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer

In the treatment of colorectal cancer patients with distant metastases, the development of new anticancer agents has considerably prolonged progression-free survival. Such survival benefits attributed to chemotherapy have increased the relative significance of local therapy in patients with limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanuki, Naoko, Takeda, Atsuya, Tsurugai, Yuichiro, Eriguchi, Takahisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529716/ https://www.ncbi.nlm.nih.gov/pubmed/35857212 http://dx.doi.org/10.1007/s11604-022-01307-9

Ejemplares similares

Three Cases of Hepatocellular Carcinoma With Massive Macrovascular Invasion Successfully Treated With Radiotherapy
por: Tsurugai, Yuichiro, et al.
Publicado: (2021)

Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions
por: Takeda, Atsuya, et al.
Publicado: (2016)

Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
por: Tsurugai, Yuichiro, et al.
Publicado: (2019)

Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
por: Narita, Atsuya, et al.
Publicado: (2019)

Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
por: Eriguchi, Takahisa, et al.
Publicado: (2022)

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
por: Nemoto, Takafumi, et al.
Publicado: (2022)

Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
por: Hara, Yu, et al.
Publicado: (2016)

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
por: Eriguchi, Takahisa, et al.
Publicado: (2016)

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
por: Eriguchi, Takahisa, et al.
Publicado: (2013)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
por: Lindberg, Sara, et al.
Publicado: (2022)

Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
por: Okada, Masahiro, et al.
Publicado: (2022)

Isolated colorectal liver metastases locally progressing after stereotactic body radiotherapy rescued with surgery
por: Blesa, J.M. Gasent, et al.
Publicado: (2009)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Stereotactic body radiotherapy for spinal oligometastases: a review on patient selection and the optimal methodology
por: Ito, Kei, et al.
Publicado: (2022)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects
por: Uto, Megumi, et al.
Publicado: (2022)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking
por: Jarraya, Hajer, et al.
Publicado: (2013)

Colorectal liver metastases: An update on multidisciplinary approach
por: Chow, Felix Che-Lok, et al.
Publicado: (2019)

Multidisciplinary approach of colorectal cancer liver metastases
por: Fiorentini, Giammaria, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results
por: Garcia-Exposito, Nagore, et al.
Publicado: (2023)

The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
por: Linskey, Mark E., et al.
Publicado: (2009)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
por: Nakamura, Ryuji, et al.
Publicado: (2020)

Risk‐adapted stereotactic body radiotherapy for patients with cervical spinal metastases
por: Wang, Huan‐Huan, et al.
Publicado: (2022)

Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis
por: Ehret, Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vurd788g1ivi27ec5nb7u97ko